KRP-116D (Kyorin Pharmaceutical)

N/A

Report date: 2025/08/13 14:18:14
NME

Base Information

Drug NameKRP-116D (Kyorin Pharmaceutical)
Drug Alias Name50% w/w dimethyl sulfoxide aqueous solution (Kyorin Pharmaceutical)KRP-116D
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell membrane permeability enhancers
TargetsNot applicable
Therapy Area/IndicationsCystitis, InterstitialSkin NeoplasmsNeoplasms, Squamous Cell +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesKyorin Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCenter For Biomedical Research IncKyorin Holdings Inc
Inactive CompaniesN/A
Active IndicationsCystitis, InterstitialSkin NeoplasmsNeoplasms, Squamous Cell +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A